JP2023505492A5 - - Google Patents

Info

Publication number
JP2023505492A5
JP2023505492A5 JP2022533410A JP2022533410A JP2023505492A5 JP 2023505492 A5 JP2023505492 A5 JP 2023505492A5 JP 2022533410 A JP2022533410 A JP 2022533410A JP 2022533410 A JP2022533410 A JP 2022533410A JP 2023505492 A5 JP2023505492 A5 JP 2023505492A5
Authority
JP
Japan
Prior art keywords
amino acid
seq
acid sequence
polypeptide
isvd
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022533410A
Other languages
English (en)
Japanese (ja)
Other versions
JP7657797B2 (ja
JP2023505492A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/084430 external-priority patent/WO2021110816A1/en
Publication of JP2023505492A publication Critical patent/JP2023505492A/ja
Publication of JP2023505492A5 publication Critical patent/JP2023505492A5/ja
Application granted granted Critical
Publication of JP7657797B2 publication Critical patent/JP7657797B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022533410A 2019-12-06 2020-12-03 TNFαおよびIL-23を標的化する免疫グロブリン単一可変ドメインを含むポリペプチド Active JP7657797B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201962944619P 2019-12-06 2019-12-06
US62/944,619 2019-12-06
EP20305056 2020-01-23
EP20305056.2 2020-01-23
EP20000090.9 2020-02-28
EP20000090 2020-02-28
EP20305216 2020-03-02
EP20305216.2 2020-03-02
PCT/EP2020/084430 WO2021110816A1 (en) 2019-12-06 2020-12-03 POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFα AND IL-23

Publications (3)

Publication Number Publication Date
JP2023505492A JP2023505492A (ja) 2023-02-09
JP2023505492A5 true JP2023505492A5 (cg-RX-API-DMAC7.html) 2023-12-07
JP7657797B2 JP7657797B2 (ja) 2025-04-07

Family

ID=73642903

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022533410A Active JP7657797B2 (ja) 2019-12-06 2020-12-03 TNFαおよびIL-23を標的化する免疫グロブリン単一可変ドメインを含むポリペプチド

Country Status (14)

Country Link
US (4) US20210188963A1 (cg-RX-API-DMAC7.html)
EP (1) EP4069733A1 (cg-RX-API-DMAC7.html)
JP (1) JP7657797B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220122652A (cg-RX-API-DMAC7.html)
CN (1) CN114981300B (cg-RX-API-DMAC7.html)
AU (1) AU2020396204A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022009799A2 (cg-RX-API-DMAC7.html)
CA (1) CA3163877A1 (cg-RX-API-DMAC7.html)
CO (1) CO2022009239A2 (cg-RX-API-DMAC7.html)
IL (1) IL293561A (cg-RX-API-DMAC7.html)
MX (1) MX2022006880A (cg-RX-API-DMAC7.html)
PH (1) PH12022551214A1 (cg-RX-API-DMAC7.html)
TW (1) TW202134269A (cg-RX-API-DMAC7.html)
WO (1) WO2021110816A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL318433A (en) 2014-05-16 2025-03-01 Ablynx Nv Improved immunoglobulin variable complexes
LT3248986T (lt) 2014-05-16 2022-03-25 Ablynx Nv Imunoglobulino kintami domenai
WO2020144164A1 (en) 2019-01-07 2020-07-16 Bactolife Aps Pathogen binding proteins
EP3930687A4 (en) 2019-02-25 2023-06-07 The University of Chicago METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS
EP4069733A1 (en) 2019-12-06 2022-10-12 Ablynx N.V. POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFalpha AND IL-23
US20240415974A1 (en) 2022-12-23 2024-12-19 Ablynx N.V. Protein-based conjugation carriers
IL322519A (en) 2023-02-17 2025-10-01 Ablynx Nv Polypeptides that bind to the neonatal fc receptor
EP4438614A1 (en) 2023-03-31 2024-10-02 Sanofi Methods for purifying heteromultimeric antibodies
US20250236673A1 (en) * 2023-12-22 2025-07-24 Ablynx N.V. Protein-based carriers for site-specific amine conjugation
CN118687298A (zh) 2024-07-29 2024-09-24 上海原能细胞生物低温设备有限公司 一种立式低温存储冰箱
CN119371530B (zh) * 2024-11-06 2025-05-20 北京科道博济生物科技有限公司 一种靶向il-23a的纳米抗体及其应用
CN121824755A (zh) * 2026-01-16 2026-04-10 天津科道博济生物科技有限公司 一种靶向il-23a的纳米检测抗体及其应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334275D1 (de) 1992-08-21 2009-05-20 Univ Bruxelles Immunoglobuline ohne Leichtkette
EP0739981A1 (en) 1995-04-25 1996-10-30 Vrije Universiteit Brussel Variable fragments of immunoglobulins - use for therapeutic or veterinary purposes
DK1027439T3 (da) 1997-10-27 2010-05-10 Bac Ip Bv Multivalente antigenbindende proteiner
NZ540194A (en) 2002-11-08 2008-07-31 Ablynx Nv Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
AU2006249144B2 (en) 2005-05-18 2011-11-17 Ablynx Nv Improved NanobodiesTM against Tumor Necrosis Factor-alpha
AU2007237501A1 (en) 2006-04-14 2007-10-25 Ablynx N.V. DP-78-like nanobodies
JP2010500876A (ja) 2006-08-18 2010-01-14 アブリンクス エン.ヴェー. Il−6媒介性シグナル伝達に関連する疾患及び障害の治療のための、il−6rに指向性を有するアミノ酸配列及びこれを含むポリペプチド
CA2706425A1 (en) * 2007-11-27 2009-06-04 Ablynx N.V. Method for obtaining polypeptide constructs comprising two or more single domain antibodies
CA3141978A1 (en) 2011-06-23 2012-12-27 Ablynx Nv Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains
LT3466972T (lt) 2011-06-23 2026-06-25 Ablynx Nv Serumo albuminą surišantys baltymai
LT3248986T (lt) 2014-05-16 2022-03-25 Ablynx Nv Imunoglobulino kintami domenai
AR102417A1 (es) 2014-11-05 2017-03-01 Lilly Co Eli Anticuerpos biespecíficos anti-tnf- / anti-il-23
EP3365371B1 (en) * 2015-10-22 2025-10-08 Ablynx NV Gitr agonists
NO2768984T3 (cg-RX-API-DMAC7.html) 2015-11-12 2018-06-09
HUE057241T2 (hu) 2015-11-13 2022-04-28 Ablynx Nv Javított, szérumalbumint kötõ immunoglobulin variábilis domének
AU2016357460B2 (en) 2015-11-18 2023-07-27 Ablynx Nv Improved serum albumin binders
EP3414268A1 (en) * 2016-02-12 2018-12-19 Ablynx NV Method for the production of immunoglobulin single variable domains
WO2018104444A1 (en) 2016-12-07 2018-06-14 Ablynx Nv Improved serum albumin binding immunoglobulin single variable domains
EP3571224B1 (en) 2017-01-17 2024-08-07 Ablynx NV Improved serum albumin binders
EP4442709A3 (en) 2017-01-17 2024-12-25 Ablynx NV Improved serum albumin binders
AR112341A1 (es) 2017-08-02 2019-10-16 Lilly Co Eli ANTICUERPOS BIESPECÍFICOS ANTI-TNF- / ANTI-IL-23 DE IgG
EP4069733A1 (en) 2019-12-06 2022-10-12 Ablynx N.V. POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING TNFalpha AND IL-23

Similar Documents

Publication Publication Date Title
JP2024167313A5 (cg-RX-API-DMAC7.html)
ES2199941T3 (es) Anticuerpos monoclonales contra el receptor de la interferona, con actividad neutralizadora contra el interferon de tipo j.
JP4294596B2 (ja) 糸球体腎炎および他の炎症性疾患の治療のための組成物および方法
CN108473563B (zh) 改进的tnf结合剂
JP2023504914A5 (cg-RX-API-DMAC7.html)
JP2016529229A5 (cg-RX-API-DMAC7.html)
JP2005503789A5 (cg-RX-API-DMAC7.html)
JP2017079785A5 (cg-RX-API-DMAC7.html)
JP2021063129A5 (cg-RX-API-DMAC7.html)
JP2011509245A5 (cg-RX-API-DMAC7.html)
JP2023553694A5 (cg-RX-API-DMAC7.html)
JP2022537780A5 (cg-RX-API-DMAC7.html)
JP2018537421A5 (cg-RX-API-DMAC7.html)
JP2008508864A5 (cg-RX-API-DMAC7.html)
RU2003126168A (ru) Терапевтические связывающие молекулы
JP2011518857A5 (cg-RX-API-DMAC7.html)
JPWO2020059847A5 (cg-RX-API-DMAC7.html)
JP2022538083A5 (cg-RX-API-DMAC7.html)
JP2025530888A5 (cg-RX-API-DMAC7.html)
JP2022531556A5 (cg-RX-API-DMAC7.html)
JP2018525032A5 (cg-RX-API-DMAC7.html)
JP2022522815A5 (cg-RX-API-DMAC7.html)
JP2023531493A5 (cg-RX-API-DMAC7.html)
RU2015129655A (ru) Антитело человека, специфичное к матапневмовирусу человека, или антиген-связывающий фрагмент указанного антитела
JP2024525213A5 (cg-RX-API-DMAC7.html)